Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hand hygiene01:23

Hand hygiene

4.5K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
4.5K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

249
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Microbiology spectrum·2026
Same author

The ESCMID Framework for Reaching Consensus in Clinical Guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Two clusters of carbapenemase-producing bacteria linked to hospital utility room wastewater drains - an outbreak report.

Antimicrobial resistance and infection control·2026
Same author

First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Investigation of VIM-1-producing <i>Enterobacter</i> spp. across Switzerland: clonal dissemination and plasmid transmission.

Antimicrobial agents and chemotherapy·2026
Same author

Signe de cils in peripheral facial palsy.

Lancet (London, England)·2026

Related Experiment Video

Updated: Oct 16, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Cutting edges in Clostridioides difficile infections.

Ana Durovic1, Sarah Tschudin-Sutter1,2

  • 1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Switzerland.

Swiss Medical Weekly
|October 15, 2021
PubMed
Summary

Clostridioides difficile infection (CDI) poses significant risks, especially recurrent cases. Newer therapies like fidaxomicin and fecal microbiota transplantation show promise in reducing CDI recurrence compared to traditional antibiotics.

More Related Videos

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.5K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K

Related Experiment Videos

Last Updated: Oct 16, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Development of a Larval Zebrafish Infection Model for Clostridioides difficile
09:13

Development of a Larval Zebrafish Infection Model for Clostridioides difficile

Published on: February 14, 2020

6.5K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Clostridioides difficile is a leading cause of hospital-acquired infections and diarrhea.
  • Recurrent Clostridioides difficile infections (CDI) significantly increase morbidity, mortality, and economic burden.
  • Approximately 20% of patients experience recurrence after initial antibiotic treatment, with subsequent recurrences rising to 45%.

Purpose of the Study:

  • To compare management recommendations for Clostridioides difficile infection (CDI) between the Swiss Society of Infectious Diseases and the IDSA/SHEA guidelines.
  • To discuss challenges in treating recurrent CDI.
  • To highlight newer therapeutic options for CDI.

Main Methods:

  • Comparative analysis of clinical practice guidelines.
  • Review of current therapeutic options for CDI.
  • Discussion of treatment challenges and recurrence factors.

Main Results:

  • Newer therapies (fidaxomicin, monoclonal antibodies, fecal microbiota transplantation) demonstrate superior efficacy in reducing CDI recurrence rates compared to traditional treatments (metronidazole, vancomycin).
  • Significant differences exist between Swiss and IDSA/SHEA guidelines regarding CDI management.
  • Recurrent CDI presents unique treatment challenges.

Conclusions:

  • Novel therapeutic strategies offer improved outcomes for managing recurrent Clostridioides difficile infections.
  • Adherence to updated guidelines and consideration of advanced therapies are crucial for effective CDI treatment.
  • Further research is needed to address persistent challenges in CDI management.